Food Allergies in Children: Why a Positive Test Is Not Always an Allergy

A positive test is a clue—not a diagnosis

Imagine a nine-month-old with eczema who develops a rash around her mouth after eating peanut butter. Her pediatrician orders a broad food allergy blood panel. The results are positive for peanut, egg, milk, wheat, soy, sesame, cashew, and fish. Does this mean her family needs to remove all eight foods from her diet? Not necessarily. In fact, doing so without a careful evaluation may create more problems than it solves.

This is one of the most important changes in how we think about food allergies: a positive blood or skin test can indicate sensitization, but sensitization is not the same thing as a clinical allergy. A child may have a positive test to a food they eat comfortably. Eliminating that food based on the test alone can unnecessarily restrict nutrition, increase anxiety, and potentially interfere with maintaining tolerance.

Start with the story, not the screening panel

When I evaluate a possible food allergy, I start with the history. What did the child eat? How soon did symptoms begin? What happened—hives, vomiting, coughing, wheezing, swelling? Has the child eaten the same food before or since without difficulty?

Immediate IgE-mediated food allergies typically cause symptoms soon after ingestion, often within minutes to a couple of hours. Eczema, chronic rashes, or isolated long-standing digestive symptoms do not automatically mean a child has an IgE-mediated food allergy. Broad screening panels are especially prone to finding positive results that are not clinically meaningful.

Targeted skin testing and blood testing can help us put the pieces together. For peanut, testing specific proteins, such as Ara h 2, may improve diagnostic precision. In selected cases, a basophil activation test provides additional information. No single test replaces the clinical history.

When an oral food challenge can change everything

When the diagnosis remains uncertain, a medically supervised oral food challenge may be the most useful next step. We give carefully measured, increasing amounts of a food while watching for symptoms and preparing to treat a reaction if one occurs. This should not be attempted at home when an allergy is suspected.

A successful challenge can remove an inaccurate allergy label and return foods to a child's diet. For the infant in our example, the goal is not to assume every positive result is dangerous. It is to identify the food or foods that truly pose a risk while preserving the rest of a varied diet.

Prevention begins earlier than we once thought

For years, parents were advised to delay allergenic foods. Research, particularly the landmark LEAP peanut study and its follow-up, changed that approach. Introducing peanut-containing foods in infancy, when appropriate, can substantially reduce the risk of peanut allergy in many children. Infants with moderate-to-severe eczema (eczema that needs regular prescription creams), an existing egg allergy, or a past reaction to a food should get individualized guidance before peanut is introduced. Continued, age-appropriate consumption matters too; introducing a food once and never offering it again is not the same as making it a regular part of the diet.

Infants with severe eczema, an existing egg allergy, or a previous reaction to a food need individualized guidance before peanut introduction. Eczema also deserves good treatment because an impaired skin barrier may contribute to sensitization. The goal is to protect the skin while teaching the immune system, through safe eating, that foods are not enemies.

We have more treatment choices than avoidance alone

For a confirmed food allergy, avoidance and readiness to treat accidental reactions remain important. But we can also discuss whether treatment could reduce the risk from accidental exposure. Options include oral immunotherapy (OIT), which uses carefully supervised, gradually increasing doses of an allergen; sublingual immunotherapy in selected settings; and omalizumab (Xolair), an anti-IgE medication approved for reducing allergic reactions from accidental exposure to one or more foods in eligible patients.

Each of these options does a different job. OIT builds tolerance over time with daily dosing. It can give strong protection, but reactions can happen along the way, so it is done under close supervision. SLIT uses much smaller doses placed under the tongue. It tends to have fewer side effects but usually gives a smaller level of protection, and it is offered only in selected settings. Omalizumab lowers the chance of a serious reaction while a child is taking it. It is a safety net, not permission to eat the food freely. The right choice depends on your child's age, asthma control, digestive history, the specific food, and what matters most to your family. We make that decision together. This is shared decision-making, not a one-size-fits-all prescription.

Know what to do in an emergency

Anaphylaxis is a medical emergency. Epinephrine is the first-line treatment—not an antihistamine. Families with a diagnosed food allergy should have prescribed epinephrine readily available, know how to use it, and follow an individualized emergency action plan. Learn about the new inhaled home epinephrine as an alternative to an auto-injector. Whatever epinephrine you use, afterwards, follow that plan and seek emergency help as directed; symptoms that persist, worsen, or return require urgent attention.

My message to parents is simple: do not let a laboratory result define your child's diet or quality of life. A thoughtful history, precise testing, and—when appropriate—a supervised food challenge can separate genuine risk from unnecessary restriction. And when an allergy is real, we now have more ways to help children live safely and confidently.

Dr. Malka is a concierge physician at Crescendo MD in Portola Valley, California, and a board-certified pediatric allergist and immunologist (FAAAAI, FAAP). He specializes in food allergy treatment and oral immunotherapy (OIT), asthma and eczema care, and concierge pediatric allergy care for children, families, and adults across the San Francisco Peninsula, including Atherton, Woodside, Menlo Park, Palo Alto, and Los Altos.